WYZGA MICHAEL S
Insider CIK 1201256 · IDIX Director · EXAS Director · OMED Director · TVRD Director · NONE Chief Executive Officer, Director · XFOR Director · AKBA Director · LOGC Director · MREO Director · ADGI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2026-01-01 | 2026-01-05 | 110,000 | — | $0 | 0 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-06-09 | 2025-06-10 | 1,500 | — | $0 | 5,555 | SEC↗ |
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2025-04-15 | 2025-04-17 | 18,441 | — | $0 | 18,441 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2025-02-05 | 2025-02-06 | 30,487 | — | $0 | 30,487 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award | 2024-06-17 | 2024-06-17 | 25,050 | $3.99 | $99.9K | 25,050 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2024-06-10 | 2024-06-11 | 45,000 | — | $0 | 121,667 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2024-02-08 | 2024-02-09 | 30,783 | — | $0 | 30,783 | SEC↗ |
| MREO Mereo BioPharma Group plc | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | P Buy | 2023-08-18 | 2023-08-22 | 25,000 | $1.20 | $30.0K | 76,667 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2023-06-13 | 2023-06-14 | 45,000 | — | $0 | 51,667 | SEC↗ |
| IVVD Invivyd, Inc. | A Award deriv | 2023-05-23 | 2023-05-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer deriv | 2022-11-16 | 2022-11-17 | 12,500 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | D To issuer | 2022-11-16 | 2022-11-17 | 3,141 | — | $0 | 0 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2022-06-17 | 2022-06-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-06-06 | 2022-06-27 | 6,667 | — | $0 | 6,667 | SEC↗ |
| ADGI Adagio Therapeutics, Inc. | A Award deriv | 2021-08-05 | 2021-08-09 | 71,186 | — | $0 | 71,186 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2021-06-11 | 2021-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2021-06-02 | 2021-06-02 | 6,000 | $9.50 | $57.0K | 6,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2021-02-26 | 2021-03-02 | 10,108 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-02-26 | 2021-03-02 | 19,021 | $130.11 | $2.47M | 2,558 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2021-02-26 | 2021-03-02 | 10,108 | $26.98 | $272.7K | 21,579 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | M Exercise deriv | 2021-01-01 | 2021-01-04 | 3,141 | — | $0 | 0 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | M Exercise | 2021-01-01 | 2021-01-04 | 3,141 | — | $0 | 3,141 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2020-07-23 | 2020-07-24 | 2,558 | — | $0 | 11,471 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-06-19 | 2020-06-23 | 3,141 | — | $0 | 3,141 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2020-06-19 | 2020-06-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-06-10 | 2020-06-11 | 3,427 | — | $0 | 3,427 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2019-12-19 | 2019-12-20 | 10,869 | — | $0 | 10,869 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-07-31 | 2019-08-02 | 2,500 | — | $0 | 10,108 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-07-31 | 2019-08-02 | 5,000 | $117.93 | $589.6K | 8,913 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-07-31 | 2019-08-02 | 2,500 | $26.98 | $67.5K | 13,913 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2019-07-25 | 2019-07-26 | 2,801 | — | $0 | 11,413 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-03-13 | 2019-04-02 | 70,324 | — | $0 | 70,324 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-03-13 | 2019-04-02 | 6,854 | — | $0 | 6,854 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-03-13 | 2019-03-14 | 70,324 | — | $0 | 70,324 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-02-28 | 2019-03-01 | 500 | $96.00 | $48.0K | 8,612 | SEC↗ |
| LOGC LogicBio Therapeutics, Inc | A Award deriv | 2018-10-18 | 2018-10-22 | 24,102 | — | $0 | 24,102 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-08-28 | 2018-08-30 | 2,468 | $74.85 | $184.7K | 9,112 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2018-07-26 | 2018-07-30 | 3,230 | — | $0 | 3,230 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2018-07-26 | 2018-07-30 | 606 | — | $0 | 11,580 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2018-06-22 | 2018-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-06-14 | 2018-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-05-10 | 2018-05-11 | 7,402 | $51.53 | $381.4K | 10,974 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2017-07-27 | 2017-07-31 | 5,273 | — | $0 | 5,273 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2017-07-27 | 2017-07-31 | 791 | — | $0 | 18,376 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2017-06-01 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2016-07-28 | 2016-08-01 | 11,547 | — | $0 | 17,585 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2016-06-22 | 2016-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-06-16 | 2016-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2015-07-23 | 2015-07-27 | 7,984 | — | $0 | 7,984 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2015-07-23 | 2015-07-27 | 6,038 | — | $0 | 6,038 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2015-06-19 | 2015-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2015-06-10 | 2015-06-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2015-02-09 | 2015-02-10 | 12,608 | — | $0 | 12,608 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 15,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 5,000 | — | $0 | 0 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | D To issuer deriv | 2014-08-05 | 2014-08-05 | 20,000 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2014-06-18 | 2014-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2014-06-05 | 2014-06-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-03-25 | 2014-03-27 | 1,500 | $17.00 | $25.5K | 1,500 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | A Award deriv | 2013-10-14 | 2013-10-16 | 27,853 | — | $0 | 27,853 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2013-06-06 | 2013-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2012-06-07 | 2012-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2012-03-01 | 2012-03-02 | 5,000 | — | $0 | 5,000 | SEC↗ |
| IDIX IDENIX PHARMACEUTICALS INC | A Award deriv | 2012-03-01 | 2012-03-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NONE Radius Health, Inc. | A Award deriv | 2011-12-15 | 2012-06-22 | 1,530,000 | $3.89 | $5.95M | 1,530,000 | SEC↗ |